Torray Investment Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-34,552
| Closed | -$2.8M | – | 94 |
|
|
2023
Q4 | $2.8M | Sell |
34,552
-1,025
| -3% | -$79.8K | 0.45% | 59 |
|
|
2023
Q3 | $2.67M | Buy |
35,577
+2,968
| +9% | +$228K | 0.47% | 59 |
|
|
2023
Q2 | $2.51M | Buy |
32,609
+281
| +0.9% | +$22.4K | 0.43% | 60 |
|
|
2023
Q1 | $2.68M | Buy |
32,328
+408
| +1% | +$33.8K | 0.48% | 57 |
|
|
2022
Q4 | $2.74M | Sell |
31,920
-13,322
| -29% | -$1.05M | 0.49% | 58 |
|
|
2022
Q3 | $2.79M | Buy |
45,242
+413
| +0.9% | +$26K | 0.56% | 51 |
|
|
2022
Q2 | $2.77M | Buy |
44,829
+457
| +1% | +$28.3K | 0.53% | 57 |
|
|
2022
Q1 | $2.64M | Buy |
44,372
+12,233
| +38% | +$782K | 0.42% | 62 |
|
|
2021
Q4 | $2.33M | Buy |
32,139
+2,402
| +8% | +$165K | 0.34% | 66 |
|
|
2021
Q3 | $2.08M | Buy |
29,737
+545
| +2% | +$38.3K | 0.32% | 63 |
|
|
2021
Q2 | $2.01M | Buy |
29,192
+4,873
| +20% | +$325K | 0.3% | 70 |
|
|
2021
Q1 | $1.57M | Buy |
24,319
+4,229
| +21% | +$273K | 0.25% | 83 |
|
|
2020
Q4 | $1.17M | Sell |
20,090
-6,332
| -24% | -$382K | 0.19% | 93 |
|
|
2020
Q3 | $1.67M | Buy |
26,422
+9,103
| +53% | +$631K | 0.31% | 69 |
|
|
2020
Q2 | $1.33M | Buy |
17,319
+531
| +3% | +$40.7K | 0.25% | 80 |
|
|
2020
Q1 | $1.25M | Buy |
+16,788
| New | +$1.16M | 0.28% | 73 |
|
|
2017
Q3 | – | Sell |
-7,358
| Closed | -$521K | – | 108 |
|
|
2017
Q2 | $521K | Sell |
7,358
-159,692
| -96% | -$10.6M | 0.05% | 87 |
|
|
2017
Q1 | $11.3M | Buy |
167,050
+1,087
| +0.7% | +$76.4K | 1.19% | 47 |
|
|
2016
Q4 | $11.9M | Sell |
165,963
-809
| -0.5% | -$60.1K | 1.27% | 45 |
|
|
2016
Q3 | $13.2M | Sell |
166,772
-130,545
| -44% | -$10.6M | 1.45% | 38 |
|
|
2016
Q2 | $24.8M | Sell |
297,317
-156,103
| -34% | -$13.9M | 1.88% | 27 |
|
|
2016
Q1 | $41.7M | Buy |
453,420
+109,025
| +32% | +$9.83M | 2.17% | 23 |
|
|
2015
Q4 | $34.8M | Buy |
344,395
+1,821
| +0.5% | +$189K | 2.59% | 15 |
|
|
2015
Q3 | $33.6M | Sell |
342,574
-20,805
| -6% | -$2.31M | 2.47% | 18 |
|
|
2015
Q2 | $42.5M | Buy |
363,379
+112,205
| +45% | +$12.3M | 2.76% | 13 |
|
|
2015
Q1 | $24.6M | Buy |
251,174
+3,330
| +1% | +$338K | 2.88% | 24 |
|
|
2014
Q4 | $23.4M | Buy |
247,844
+33,700
| +16% | +$3.49M | 1.96% | 24 |
|
|
2014
Q3 | $22.8M | Buy |
214,144
+15,680
| +8% | +$1.54M | 2.07% | 20 |
|
|
2014
Q2 | $16.5M | Buy |
198,464
+126,045
| +174% | +$9.81M | 1.67% | 25 |
|
|
2014
Q1 | $5.13M | Buy |
72,419
+23,943
| +49% | +$1.88M | 0.87% | 55 |
|
|
2013
Q4 | $3.64M | Sell |
48,476
-22,485
| -32% | -$1.57M | 0.76% | 50 |
|
|
2013
Q3 | $4.46M | Sell |
70,961
-4,182
| -6% | -$250K | 0.96% | 38 |
|
|
2013
Q2 | $3.85M | Buy |
+75,143
| New | +$3.92M | 0.84% | 41 |
|
Other funds holding GILD
Torray Investment Partners's GILD Position: Q1 2024 in Review
Torray Investment Partners sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 34,552 shares — an estimated $2.8M sold.
Torray Investment Partners first reported a position in GILD in Q2 2013 and held it in 33 quarters. The position peaked at $42.5M in Q2 2015. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Torray Investment Partners reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Torray Investment Partners sold 34,552 Gilead Sciences shares in Q1 2024, an estimated $2.8M.
- Torray Investment Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 33 quarters.
- Torray Investment Partners's Gilead Sciences position peaked at $42.5M in Q2 2015.
- 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Torray Investment Partners's 13F filing for Q1 2024, filed 9 May 2024.